- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
240 results for dgse
Why Moderna Stock Looks Quite Risky
Data from the Phase 1 trial of Moderna’s coronavirus vaccine was mixed, making MRNA stock risky at its current levels.
Slim Vaccine Chances Make iBio Stock Too Speculative Here
Every investor is betting on a vaccine. Unfortunately, the case for IBIO stock is simply too speculative, as its trials remain under wraps.
With Ocugen Stock: Follow The Lead of Traders and ‘Sell The News’
With its chances of experiencing another sharp slide in price likely. If you own OCGN stock today, cash out ASAP to avoid holding the bag.…
What Will the Stock Market Do Today? 3 Big Stories to Watch.
So what will the stock market do today? All eyes are on an update to the Elon Musk Bitcoin saga and NVAX stock.
Are Children the Solution to Novavax’s Vaccine Problem?
Canada’s vaccination rate is about to pass the U.S. That does not bode well for Novavax and NVAX stock. Are children the company’s savior?
Why CureVac Might Soar From Here
The coronavirus vaccine play is crowded and CureVac stock needs to win more deals to get noticed
Positive Clinical Results Put Nkarta Stock on the Fast Track
NKTX stock is a fast mover, and a recent share-price bump came in the wake of exciting data from a “killer cell” anti-cancer research program.
Vaccine Backlog Raises New Questions About Moderna
As one of the leaders in the Covid-19 vaccine race, Moderna’s success boosted MRNA stock. But with real-time obstacles coming into the picture, the narrative…
Inovio Stock Will Tread Water Working on a Coronavirus Vaccine
Inovio’s COVID-19 vaccine faces huge hurdles. INO stock will tread water until its manufacturing and financing issues are overcome.
The Pandemic Is Not Over, And Novavax Is a Strong Contender
Despite the delays in FDA approval, Novavax has made strong strides in the industry, making NVAX stock is a great pharma stock to buy.
SRNE Stock: Sorrento Therapeutics Pops on Plans to Launch Drug Trials
Sorrento Therapeutics just announced plans to launch human trials of its antibody drug. Here’s why else SRNE stock is rallying.
Novavax (NVAX) Stock Pops Ahead of FDA Approval
NVAX stock has risen nearly 10% in the past five trading sessions on expectations that the FDA is going to approve its Covid-19 vaccine.
4 Electrical Equipment Stocks to Sell Now
This week, 4 Electrical Equipment stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
GlaxoSmithKline plc (ADR) (GSK) Seeks FDA Approval for New Shingles Vaccine
GlaxoSmithKline (GSK), a healthcare company, is seeking approval from the U.S. Food and Drug Administration for a shingles vaccine.
Why BioNTech Is the Better Biotech Buy
If you’re trying to decide who is the real winner out of the Pfizer and BioNTech partnership, BNTX takes the cake — and here’s why.
For ChargePoint Stock, Earnings Suddenly Are Crucial
Amid an EV selloff, CHPT stock has plunged. Though Q4 won’t determine its long-term outlook, CHPT and the sector need a dose of optimism.
The CDC Just Gave Novavax (NVAX) Stock a Big Boost
Novavax stock is up 6% today after the U.S. Centers for Disease Control and Prevention (CDC) approved its two-dose Covid-19 vaccine for use in adults.
Aggressive Investors Have No Excuse for Not Owning Moderna
Canada just ordered 20 million doses of Moderna’s Covid-19 vaccine. That’s excellent news for anyone who owns MRNA stock, Canadians included.
Why the New Covid-19 Strain Matters for Pfizer Stakeholders
With Pfizer delivering Covid-19 vaccines, PFE stock appears to be the pandemic’s winner. However, a new strain of SARS-CoV-2 and fresh competition may apply some…
This Is Why I’d Still Avoid IBio for Now
With no real vaccine news to speak of, I’d avoid the IBIO stock for now. If they can get something going, it may be worth…
10 – 10 of 240 results
